BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 787654)

  • 1. Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.
    Fritze D; Kern DH; Pilch YH
    Klin Wochenschr; 1976 Sep; 54(18):851-63. PubMed ID: 787654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of antitumor immunity by "immune" RNA.
    Pilch YH; Fritze D; Waldman SR; Kern DH
    Curr Top Microbiol Immunol; 1975; 72():157-90. PubMed ID: 767056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of immune ribonucleic acids in stimulating antitumor immunity].
    Luganova IS; Blinov MN
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Mar; (3):23-30. PubMed ID: 373332
    [No Abstract]   [Full Text] [Related]  

  • 6. Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA.
    Kern DH; Fritze D; Drogemuller CR; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):97-103. PubMed ID: 1003510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of immune responses to tumor antigens by immune RNA.
    Pilch YH
    Prog Exp Tumor Res; 1980; 25():163-77. PubMed ID: 6986630
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of immune RNA in the immunotherapy of malignant brain tumor (author's transl)].
    Nakamura O; Takakura K
    No To Shinkei; 1982 Apr; 34(4):333-9. PubMed ID: 6178420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
    Skinner DG; Dekernion JB; Brower PA; Ramming KP; Pilch YH
    J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some perspectives on the transfer of cell-mediated immunity by immune-RNA.
    Dray S; Braun DP
    Mol Cell Biochem; 1979 May; 25(1):15-31. PubMed ID: 112379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune RNA: its application in cancer immunotherapy].
    Genaro AM; Cremaschi GA
    Acta Physiol Lat Am; 1983; 33(1):21-31. PubMed ID: 6197863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.
    Schlager SI; Paque RE; Dray S
    Cancer Res; 1975 Aug; 35(8):1907-14. PubMed ID: 167938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of immunology in the diagnosis and treatment of cancer.
    Humphrey LJ; Pierce GE
    Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
    Dodd MC; Scheetz ME; Rossio JL
    Ann N Y Acad Sci; 1973 May; 207():454-67. PubMed ID: 4517721
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA; Dekernion JB; Ramming KP
    J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of xenogeneic immune RNA on normal human lymphocytes against human osteosarcoma cells in vitro.
    Singh I; Tsang KY; Blakemore WS
    J Natl Cancer Inst; 1977 Mar; 58(3):505-10. PubMed ID: 264978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
    Richie JP; Wang BS; Steele GD; Wilson RE; Mannick JA
    J Urol; 1981 Jul; 126(1):24-8. PubMed ID: 6166758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune RNA in the immunotherapy of cancer.
    Pilch YH; Fritze D; Kern DH
    Med Clin North Am; 1976 May; 60(3):567-83. PubMed ID: 1271893
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
    Veltman LL; Kern DH; Pilch YH
    Am J Obstet Gynecol; 1974 Aug; 119(7):959-65. PubMed ID: 4135321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.